Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Illumina Ventures
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Menten AIFounded 2018 • 11-50 employees
Menten AI designs peptide therapeutics using computational protein design combined with quantum and classical optimisation. Founded in 2018…
Xaira TherapeuticsFounded 2023 • 51-200 employees • 21 roles
Xaira Therapeutics uses generative models for protein design and drug discovery. It launched with one of the largest initial funding rounds…
Discover our non-toxic dyes for live-cell imaging. Saguaro dyes are data-rich and do not require any wash step, pushing beyond the limits…
Isomorphic LabsFounded 2021 • 51-200 employees • 24 roles
Isomorphic Labs is a London drug discovery company founded in 2021 as an Alphabet spin-out from Google DeepMind. It applies AlphaFold and…
Talus Bio1-10 employees
Talus Bio makes the regulome—the control layer of gene expression—visible, measuring and modulating gene regulators in live cells to access…
Iambic TherapeuticsConvertible Note $75k · 2 yr ago • Founded 2019
Iambic Therapeutics combines machine learning with automated chemistry to discover small molecule drugs. Its NeuralPLexer models predict…

Overview

Building the world’s largest atlas of engineered protein interaction data. DeepSeq’s Function-First platform maps live-cell PPI physics to engineer drugs that go beyond simple binder prediction.